TrialJournal of atherosclerosis and thrombosis2024

Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study.

Mitsuhide Takeshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.